Trials / Conditions / Liver Transplant Infection

Liver Transplant Infection

9 registered clinical trials studyying Liver Transplant Infection — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Rezafungin Prophylaxis in Liver Transplant NCT06774144	Fernanda P Silveira, MD, MS	Phase 3
Not Yet Recruiting	Application of Nanopore Adaptive Sequencing NCT06542042	Shenzhen Third People's Hospital	—
Recruiting	Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Be NCT06718517	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Enrolling By Invitation	Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant NCT05224583	Methodist Health System	—
Unknown	Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocom NCT04410471	Magdalena Salcedo	—
Withdrawn	Pharmacological Study of Cefazolin Antibioprophylaxis in Liver Transplantation NCT04280237	University Hospital, Tours	—
Completed	CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients NCT03924219	Vanderbilt University Medical Center	—
Terminated	Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation NCT03723824	Taichung Veterans General Hospital	Phase 4
Completed	Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant NCT03389360	National Hepatology & Tropical Medicine Research Institute	—